 | Up a level |
Gorog, Diana A, Gue, Ying X 
ORCID: 0000-0001-9994-8915, Chao, Tze-Fan, Fauchier, Laurent, Ferreiro, Jose Luis, Huber, Kurt, Konstantinidis, Stavros V, Lane, Deirdre A ORCID: 0000-0002-5604-9378, Marin, Francisco, Oldgren, Jonas et al (show 7 more authors)
(2022)
Assessment and mitigation of bleeding risk in atrial fibrillation and venous thromboembolism: A Position Paper from the ESC Working Group on Thrombosis, in collaboration with the European Heart Rhythm Association, the Association for Acute CardioVascular Care and the Asia-Pacific Heart Rhythm Society.
EUROPACE, 24 (11).
pp. 1844-1871.
Koziel, Monika, Al-Saady, Naab, Hjortshoj, Soren P, Goudev, Assen, Huber, Kurt, Cohen, Ariel, Jin, James, Melino, Michael, Winters, Shannon M, Goette, Andreas et al (show 1 more authors)
(2020)
Edoxaban versus warfarin in vitamin K antagonist experienced and naive patients from the edoxaban versus warfarin in subjects undergoing cardioversion of atrial fibrillation (ENSURE-AF) randomised trial.
CLINICAL RESEARCH IN CARDIOLOGY, 109 (8).
pp. 1018-1024.